• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid.

作者信息

Jones B M, Kinghorn G R, Duerden B I

机构信息

Department of Medical Microbiology, University of Sheffield Medical School, UK.

出版信息

Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):551-3. doi: 10.1007/BF01962614.

DOI:10.1007/BF01962614
PMID:3141171
Abstract

The in vitro activity of the new macrolide azithromycin and erythromycin against Haemophilus ducreyi, Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. was compared. Gardnerella vaginalis, Mobiluncus spp. and Haemophilus ducreyi were highly susceptible to both agents but azithromycin was more effective overall against all three groups of organisms. The activity of both antibiotics against Bacteroides spp. varied greatly, but azithromycin was again more active. Collectively, 62% of all Bacteroides strains were susceptible to erythromycin (MIC 1 mg/1) and 74% were susceptible to azithromycin.

摘要

相似文献

1
In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid.
Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):551-3. doi: 10.1007/BF01962614.
2
In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
J Antimicrob Chemother. 1985 Aug;16(2):189-97. doi: 10.1093/jac/16.2.189.
3
In vitro susceptibility of Gardnerella vaginalis and Bacteroides organisms, associated with nonspecific vaginitis, to sulfonamide preparations.与非特异性阴道炎相关的阴道加德纳菌和拟杆菌对磺胺制剂的体外敏感性。
Antimicrob Agents Chemother. 1982 Jun;21(6):870-2. doi: 10.1128/AAC.21.6.870.
4
In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.来自泰国和美国的杜克嗜血杆菌分离株对目前推荐的以及新型软下疳治疗药物的体外敏感性。
Antimicrob Agents Chemother. 1993 Jul;37(7):1552-5. doi: 10.1128/AAC.37.7.1552.
5
In vitro susceptibility of Haemophilus ducreyi to several antibiotics.杜克嗜血杆菌对多种抗生素的体外敏感性
Microbios. 1993;74(299):103-9.
6
Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.多种肠胃外和口服抗菌剂对地方性杜克雷嗜血杆菌的体外活性比较。
Antimicrob Agents Chemother. 1993 Sep;37(9):1986-8. doi: 10.1128/AAC.37.9.1986.
7
In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
J Antimicrob Chemother. 1990 Jan;25 Suppl A:1-5. doi: 10.1093/jac/25.suppl_a.1.
8
Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases.
J Antimicrob Chemother. 1992 Apr;29 Suppl A:13-7. doi: 10.1093/jac/29.suppl_a.13.
9
Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.美国杜克雷嗜血杆菌分离株的体外抗菌药敏性与β-内酰胺酶质粒含量之间的相关性
Antimicrob Agents Chemother. 1992 Aug;36(8):1639-43. doi: 10.1128/AAC.36.8.1639.
10
Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.卢旺达出现杜克雷嗜血杆菌对甲氧苄啶-磺胺甲恶唑耐药的情况。
Antimicrob Agents Chemother. 1994 Jul;38(7):1647-8. doi: 10.1128/AAC.38.7.1647.

引用本文的文献

1
Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections.阿奇霉素脂质体作为一种治疗宫颈阴道细菌感染的局部治疗新方法。
Int J Nanomedicine. 2019 Jul 30;14:5957-5976. doi: 10.2147/IJN.S211691. eCollection 2019.
2
On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.改善生育结局的途径?阿奇霉素和可治愈性传播感染的系统评价。
Expert Rev Anti Infect Ther. 2013 Dec;11(12):1303-32. doi: 10.1586/14787210.2013.851601. Epub 2013 Nov 6.
3
In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.

本文引用的文献

1
Characteristics of motile curved rods in vaginal secretions.阴道分泌物中活动弯曲杆菌的特征
J Med Microbiol. 1983 May;16(2):175-82. doi: 10.1099/00222615-16-2-175.
2
An overview of the diagnosis and treatment of Gardnerella vaginalis and Bacteroides associated vaginitis.阴道加德纳菌和拟杆菌相关性阴道炎的诊断与治疗概述
Eur J Clin Microbiol. 1982 Oct;1(5):320-5. doi: 10.1007/BF02019980.
3
Sheffield medium for cultivation of Haemophilus ducreyi.用于培养杜克雷嗜血杆菌的谢菲尔德培养基。
来自泰国和美国的杜克嗜血杆菌分离株对目前推荐的以及新型软下疳治疗药物的体外敏感性。
Antimicrob Agents Chemother. 1993 Jul;37(7):1552-5. doi: 10.1128/AAC.37.7.1552.
4
Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.阿奇霉素、克拉霉素、红霉素和洛美沙星对肺炎支原体、人型支原体和解脲脲原体的体外活性比较
Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):838-41. doi: 10.1007/BF01967388.
5
Spectrum of activity of azithromycin.阿奇霉素的活性谱
Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):813-20. doi: 10.1007/BF01975833.
6
Gardnerella vaginalis: characteristics, clinical considerations, and controversies.阴道加德纳菌:特征、临床考量及争议
Clin Microbiol Rev. 1992 Jul;5(3):213-37. doi: 10.1128/CMR.5.3.213.
7
Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.美国杜克雷嗜血杆菌分离株的体外抗菌药敏性与β-内酰胺酶质粒含量之间的相关性
Antimicrob Agents Chemother. 1992 Aug;36(8):1639-43. doi: 10.1128/AAC.36.8.1639.
8
Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.阿奇霉素:抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1992 Nov;44(5):750-99. doi: 10.2165/00003495-199244050-00007.
Br J Vener Dis. 1984 Jun;60(3):196-8. doi: 10.1136/sti.60.3.196.
4
Antimicrobial susceptibility of comma-shaped bacteria isolated from the vagina.从阴道分离出的逗点状细菌的抗菌药敏性。
Scand J Infect Dis Suppl. 1983;40:81-4.
5
Gardnerella vaginalis-associated vaginitis--a 'new' sexually transmitted disease.
Med Lab Sci. 1983 Jan;40(1):53-7.
6
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.17种抗菌剂对阴道加德纳菌的体外活性
Eur J Clin Microbiol. 1982 Oct;1(5):298-300. doi: 10.1007/BF02019975.
7
A scheme for the identification of clinical isolates of Gram-negative anaerobic bacilli by conventional bacteriological tests.一种通过传统细菌学检测鉴定革兰氏阴性厌氧杆菌临床分离株的方案。
J Med Microbiol. 1980 May;13(2):231-45. doi: 10.1099/00222615-13-2-231.
8
In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
J Antimicrob Chemother. 1985 Aug;16(2):189-97. doi: 10.1093/jac/16.2.189.
9
Susceptibility of Haemophilus ducreyi to ampicillin and sulbactam in vitro.杜克雷嗜血杆菌对氨苄西林和舒巴坦的体外敏感性
Antimicrob Agents Chemother. 1986 Jun;29(6):1110-2. doi: 10.1128/AAC.29.6.1110.